Regulatory Compliance for Biologics and Biosimilars Market By Application: Compliance Solutions, Quality Management, By End-Use: Manufacturers, Biotech Companies, By Region: North America, Europe, Asia Pacific, Segment Forecasts: 2024 - 2030
Regulatory Compliance for Biologics and Biosimilars Market Trends
The regulatory compliance for biologics and biosimilars market was valued at USD 5.1 billion in 2024 and is projected to grow at a CAGR of 10.2% from 2025 to 2030. Ensuring compliance with regulatory standards is critical for the successful development and commercialization of biologics and biosimilars.
Product Insights
Compliance solutions accounted for the largest market share in 2024, contributing 66.5% of total revenue. Quality management solutions are also gaining importance as manufacturers strive to meet stringent regulatory requirements.
End-Use Insights
Manufacturers represented the largest end-use segment in 2024, holding a 70.3% market share, as they seek compliance solutions to navigate complex regulatory landscapes. Biotech companies are also investing in compliance services to ensure product safety and efficacy.
Regional Insights
North America dominated the market with a 52.4% share in 2024, driven by stringent regulatory requirements and high investments in compliance infrastructure. The Europe region is anticipated to grow steadily, supported by regulatory harmonization efforts.
GET A FREE SAMPLE
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.